date：2019-01-02 Views：9011 times
查看研報附件：信達國際-康臣藥業1681：2018年上半年收入實現穩定增長，推薦買入評級，目標價9.6港元。
Prev：China / Hong Kong Company Guide Consun Pharmaceutical Group
Next：None
400-930-1681
service@chinaconsun.com
71 Dongpeng Avenue, Huangpu District, Guangzhou
Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration
粵ICP備15001491號Design: uweb
